FDA issues proposed guidelines for developing drugs for Alzheimer’s disease

Author(s):

On Feb. 7, 2013, the U.S. Food and Drug Administration (FDA) issued a proposal designed to help companies developing new treatments for patients in the early stages of Alzheimer’s disease. Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here